DEMANT A S/ADR (OTCMKTS:WILYY) Raised to Hold at Zacks Investment Research

Zacks Investment Research upgraded shares of DEMANT A S/ADR (OTCMKTS:WILYY) from a sell rating to a hold rating in a research report report published on Saturday, Zacks.com reports.

According to Zacks, “Demant A/S is engaged in the healthcare industry. It develops, manufactures and sells products and equipment designed to aid the hearing and communication of individuals. The company’s business area consists of Hearing Devices, Hearing Implants, Diagnostic Instruments and Personal Communication. Demant A/S, formerly known as William Demant Holding A/S, is based in Smorum, Denmark. “

OTCMKTS:WILYY remained flat at $$12.21 during mid-day trading on Friday. The firm has a market capitalization of $6.67 billion, a PE ratio of 21.05, a PEG ratio of 1.86 and a beta of 0.40. The business’s 50 day moving average is $12.74 and its 200-day moving average is $15.00. DEMANT A S/ADR has a 52 week low of $12.21 and a 52 week high of $17.60.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with MarketBeat.com's FREE daily email newsletter.

About DEMANT A S/ADR

Demant A/S, a hearing healthcare company, develops, manufactures, and sells products and equipment to enhance people's hearing in Europe, North America, the Pacific, Asia, and internationally. Its products include hearing devices and implants; diagnostic instruments; and personal communication systems, such as headsets and solutions for the professional call center and office market, as well as consumer headsets for the gaming and mobile segments.

Featured Article: What are the benefits of momentum investing?

Get a free copy of the Zacks research report on DEMANT A S/ADR (WILYY)

For more information about research offerings from Zacks Investment Research, visit Zacks.com

Leave a Reply

Your email address will not be published. Required fields are marked *

*